Healthcare Spending Trends/Reimbursement Policies: Changes in healthcare budgets, insurance coverage, and reimbursement rates (e.g., Medicare payment rates for diagnostic tests) directly impact demand and revenue for diagnostic companies like Biomerica.

Regulatory Environment for Medical Devices/Diagnostics: Stringent regulatory approval processes, evolving standards (e.g., MHRA registration, CE-IVDR certification, FDA approvals), and international authorizations can significantly affect product launch timelines and market access.

Prevalence of Gastrointestinal and Inflammatory Diseases: The underlying market demand for Biomerica's specialized diagnostic and therapeutic products is tied to the global incidence, diagnosis rates, and management strategies for conditions such as Irritable Bowel Syndrome (IBS) and Helicobacter pylori (H. pylori) infections.